+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expanding), Indication (Chronic Total Occlusion, Myocardial Infarction, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expanding), Indication (Chronic Total Occlusion, Myocardial Infarction, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Bioabsorbable Sirolimus-eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expanding), Indication (Chronic Total Occlusion, Myocardial Infarction, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083021
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Over the past decade, breakthroughs in polymer science and drug-eluting technologies have coalesced to give rise to fully bioabsorbable sirolimus-eluting stents that promise to reshape the coronary intervention paradigm. These devices leverage a dissolvable scaffold composed of biocompatible polymers that gradually degrade within the vessel lumen, eliminating the long-term presence of foreign material and mitigating risks associated with permanent metallic implants. As the scaffold resorbs, it leaves behind a restored arterial segment capable of preserving natural vasomotion and endothelial function.

This shift toward transient scaffolding has been propelled by rigorous preclinical evaluations and progressive clinical trials demonstrating favorable safety profiles, reduced late-stage restenosis, and diminished incidence of stent thrombosis. Transitional phrases from early feasibility studies to pivotal trials underscore a maturing evidence base that supports regulatory approvals and growing clinical adoption. Consequently, stakeholders across the healthcare ecosystem are reexamining revascularization strategies with an emphasis on patient-centric outcomes and life-cycle management of coronary disease.

Emerging Clinical and Technological Disruptions Shaping the Future of Bioabsorbable Coronary Stent Therapies Across Diverse Healthcare Environments

Converging technological breakthroughs, evolving clinical guidelines, and shifting reimbursement frameworks have ignited transformative shifts in the bioabsorbable stent landscape. Technologically, the refinement of polymer backbones and optimized drug-release kinetics has enhanced scaffold integrity during critical healing phases while ensuring complete resorption within a predictable time window. In parallel, advances in imaging modalities such as optical coherence tomography have facilitated real-time assessment of scaffold integration and vessel healing, reinforcing clinician confidence in these next-generation devices.

Clinically driven revisions to practice guidelines now emphasize the long-term safety benefits of temporary scaffolding for selected patient cohorts, particularly those at heightened risk of late stent complications or requiring future coronary interventions. Additionally, dynamic reimbursement policies in certain markets have begun to recognize the cost-offsets associated with reduced adverse events over the implant’s life cycle. Together, these developments create powerful momentum toward broader deployment of bioabsorbable sirolimus-eluting platforms across acute coronary syndromes and elective revascularization procedures.

Assessing the Ripple Effects of United States Tariff Adjustments on Advanced Cardiovascular Medical Device Supply Chains and Pricing Paradigms in 2025

The introduction of new tariff measures in 2025 has ushered in a period of recalibration across global cardiovascular device supply chains. Increased duties on imported raw materials and finished cardiovascular devices have exerted upward pressure on manufacturing costs, prompting original equipment manufacturers to reassess production footprints and sourcing strategies. Many firms have initiated raw material diversification programs, shifting procurement to tariff-free jurisdictions or repatriating certain manufacturing processes to domestic facilities to shield against escalating duties.

At the same time, pricing strategies are evolving to balance margin preservation with market access imperatives. Companies are negotiating revised contracts with healthcare providers, exploring value-based pricing models, and seeking to optimize product portfolios by focusing on core, high-margin offerings. The cumulative effect of these tariff adjustments has reinforced the importance of supply chain agility, vertical integration, and strategic partnerships to maintain resilient distribution networks while delivering cost-effective therapies to clinicians and patients.

Deep Dive into Candid Segmentation of Product, Clinical Indications, End Users and Distribution Channels Driving Growth and Innovation in Coronary Stent Markets

In evaluating the market through a multidimensional lens, product type segmentation reveals distinct trajectories for balloon expandable devices, which include medium, thick, and thin strut configurations, versus self-expanding scaffolds categorized similarly by strut thickness. Balloon expandable platforms currently command attention for their precise deployment control and compatibility with complex lesion subsets, while self-expanding alternatives are lauded for their adaptability in tortuous anatomies and enhanced radial force dynamics.

Clinical indication segmentation further accentuates divergent adoption patterns across chronic total occlusion cases, acute myocardial infarction subtypes NSTEMI and STEMI, and stable angina presentations spanning bifurcation lesions, large, multi, single, and small vessel interventions. In the acute myocardial infarction setting, select bioabsorbable designs are emerging as preferred options for patients requiring subsequent imaging or staged interventions. Conversely, stable angina populations, particularly those with complex vessel geometries, benefit from the controlled degradation profiles that support vessel remodeling.

End users range from ambulatory surgical centers, including both hospital-owned facilities and independent clinics, through private and public hospitals, to specialty cardiology clinics emphasizing outpatient management. The distribution ecosystem encompasses direct tendering agreements with institutional purchasers, retail pharmacy channels segmented into offline retail and wholesale outlets, and emerging online pharmacy platforms, as well as traditional wholesale distribution networks. Each distribution pathway exerts nuanced influences on adoption velocity, reimbursement negotiations, and post-market support models.

Mapping Regional Dynamics Influencing the Adoption of Bioabsorbable Sirolimus-Eluting Stents across Americas, Europe Middle East Africa and Asia-Pacific Sectors

Regional dynamics play a critical role in shaping the uptake of bioabsorbable sirolimus-eluting stents across the Americas, where a mature healthcare infrastructure and progressive reimbursement schemes support rapid adoption in urban centers while rural outreach remains an emerging focus. In Europe, Middle East & Africa, heterogeneous regulatory landscapes and varied economic environments give rise to differentiated market entry strategies; Western Europe’s harmonized regulatory standards facilitate commercialization, whereas emerging economies in the Middle East and Africa demand localized partnerships and adaptive pricing frameworks.

Meanwhile, Asia-Pacific markets exhibit multifaceted growth drivers influenced by population demographics, incidence rates of coronary artery disease, and government initiatives to bolster domestic device manufacturing. In advanced economies such as Japan and Australia, stringent device approval processes drive robust clinical data generation, whereas emerging markets in Southeast Asia and India prioritize cost-effective solutions and technology transfer partnerships. These regional nuances necessitate tailored market access strategies and local engagement models to fully capitalize on the diverse opportunities each geography presents.

Competitive Landscape and Profiles of Pioneering Corporations Steering Innovation in Bioabsorbable Coronary Stent Solutions on a Global Scale

The competitive landscape is defined by established leaders and nimble challengers leveraging distinct value propositions. Abbott Vascular has advanced its polymer platform with iterative design enhancements focused on minimizing scaffold recoil and optimizing drug kinetics. Boston Scientific has emphasized an integrated approach, combining scaffold innovation with proprietary imaging and diagnostic tools to support procedural precision and post-implant monitoring. Medtronic’s research initiatives are centered on bioresorbable alloys and next-generation polymers engineered for tailored degradation timelines and enhanced mechanical robustness.

Emerging manufacturers such as Biotronik and Terumo are differentiating through targeted clinical applications and strategic alliances that amplify distribution reach and post-market surveillance capabilities. Additionally, specialized contract research organizations and component suppliers are stepping into collaborative research partnerships, accelerating the pace of innovation through shared development platforms. Collectively, these competitive dynamics underscore the importance of agile product development, evidence-driven positioning, and ecosystem alliances in maintaining market relevance.

Strategic Roadmap and Actionable Insights for Industry Executives to Capitalize on Next-Generation Bioabsorbable Stent Developments and Market Opportunities

Industry leaders should prioritize cross-functional collaboration between R&D, clinical affairs, and market access teams to streamline the development of bioabsorbable stent iterations that address unmet clinical needs. Early engagement with regulatory authorities can expedite approval pathways and foster harmonized data requirements, while real-world evidence generation should be integrated with pivotal trials to demonstrate long-term outcomes and economic value.

Manufacturers must also fortify supply chain resilience through geographic diversification of critical suppliers and the establishment of strategic buffer inventories to mitigate tariff impacts and geopolitical disruptions. Embracing digital platforms for remote proctoring, virtual training programs, and telemonitoring services can enhance physician confidence and patient follow-up adherence. Finally, cultivating targeted partnerships with healthcare payers and integrated delivery networks will be essential to articulate bundled payment models, highlight total cost of care reductions, and secure favorable reimbursement arrangements.

Comprehensive Research Methodology Integrating Primary Expert Perspectives and Secondary Data Sources to Ensure Robust Insights into Coronary Stent Technologies

This research integrates primary qualitative insights from interventional cardiologists, materials scientists, regulatory specialists, and procurement leaders across diverse geographies. Structured interviews and advisory board consultations informed key assumptions regarding clinical use cases, device performance benchmarks, and evolving health economic priorities. Concurrently, secondary data sources including peer-reviewed journals, regulatory approval databases, clinical trial registries, and published health technology assessments provided quantitative validation of market trends and adoption drivers.

Data triangulation methods ensured the robustness of synthesized findings, while iterative peer reviews with subject matter experts validated the objectivity and relevance of strategic recommendations. Geographic coverage spanned mature and emerging markets, enabling comparative analyses and regional deep dives. The methodology underscores a transparent, reproducible approach to deriving actionable intelligence that aligns with the highest standards of evidence-based market research.

Concluding Synthesis Highlighting Key Takeaways and Implications from the Bioabsorbable Sirolimus-Eluting Stent Report for Cardiovascular Decision-Makers

In synthesizing the collective insights from technological innovations, tariff dynamics, segmentation analyses, regional variations, and competitive strategies, it becomes evident that bioabsorbable sirolimus-eluting stents are poised to redefine coronary intervention. Stakeholders must navigate a complex ecosystem of evolving clinical guidelines, shifting reimbursement paradigms, and supply chain realignments to capitalize on this transformative technology.

Decision-makers in clinical, regulatory, and commercial functions are encouraged to harness the detailed analyses presented herein to inform product development roadmaps, market entry strategies, and partnership models. By prioritizing evidence generation, localization of market access approaches, and organizational agility, industry participants can unlock the full potential of bioabsorbable stent therapies and deliver sustainable value to patients and healthcare systems alike.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Balloon Expandable
      • Medium Strut
      • Thick Strut
      • Thin Strut
    • Self Expanding
      • Medium Strut
      • Thick Strut
      • Thin Strut
  • Indication
    • Chronic Total Occlusion
    • Myocardial Infarction
      • NSTEMI
      • STEMI
    • Stable Angina
      • Bifurcation
      • Large Vessel
      • Multi Vessel
      • Single Vessel
      • Small Vessel
    • Unstable Angina
  • End User
    • Ambulatory Surgical Center
      • Hospital Owned
      • Independent
    • Hospital
      • Private Hospital
      • Public Hospital
    • Specialty Cardiology Clinic
  • Distribution Channel
    • Direct Tendering
    • Retail Pharmacy
      • Offline Channel
        • Retail
        • Wholesale
      • Online Channel
    • Wholesale Distribution
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • BIOTRONIK SE & Co. KG
  • Elixir Medical Corporation
  • REVA Medical, Inc.
  • Translumina GmbH
  • Relisys Medical Devices Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of next-generation biodegradable polymers optimizing sirolimus release kinetics for complex coronary lesions
5.2. Emergence of personalized stent designs integrating patient-specific coronary artery imaging and modeling data
5.3. Regulatory momentum following FDA breakthrough device designation for bioabsorbable sirolimus-eluting stent platforms
5.4. Long-term clinical evidence demonstrating reduced late stent thrombosis with novel absorbable sirolimus stents
5.5. Strategic partnerships driving manufacturing scale-up of bioresorbable sirolimus-eluting coronary scaffolds
5.6. Market expansion in Asia Pacific fueled by cost-effective bioabsorbable stents for rising cardiovascular disease burden
5.7. Integration of real-world registry data to validate safety and efficacy of sirolimus-eluting bioabsorbable stents
5.8. Advancements in polymer chemistry enabling controlled sirolimus release over 12 to 18 months in coronary applications
5.9. Mergers and acquisitions accelerating consolidation among key players in absorbable coronary stent sector
5.10. Cost-benefit analyses highlighting reduced long-term healthcare expenditure with bioabsorbable sirolimus scaffolds
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Product Type
8.1. Introduction
8.2. Balloon Expandable
8.2.1. Medium Strut
8.2.2. Thick Strut
8.2.3. Thin Strut
8.3. Self Expanding
8.3.1. Medium Strut
8.3.2. Thick Strut
8.3.3. Thin Strut
9. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Indication
9.1. Introduction
9.2. Chronic Total Occlusion
9.3. Myocardial Infarction
9.3.1. NSTEMI
9.3.2. STEMI
9.4. Stable Angina
9.4.1. Bifurcation
9.4.2. Large Vessel
9.4.3. Multi Vessel
9.4.4. Single Vessel
9.4.5. Small Vessel
9.5. Unstable Angina
10. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.2.1. Hospital Owned
10.2.2. Independent
10.3. Hospital
10.3.1. Private Hospital
10.3.2. Public Hospital
10.4. Specialty Cardiology Clinic
11. Bioabsorbable Sirolimus-eluting Coronary Stent System Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tendering
11.3. Retail Pharmacy
11.3.1. Offline Channel
11.3.1.1. Retail
11.3.1.2. Wholesale
11.3.2. Online Channel
11.4. Wholesale Distribution
12. Americas Bioabsorbable Sirolimus-eluting Coronary Stent System Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bioabsorbable Sirolimus-eluting Coronary Stent System Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bioabsorbable Sirolimus-eluting Coronary Stent System Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. BIOTRONIK SE & Co. KG
15.3.2. Elixir Medical Corporation
15.3.3. REVA Medical, Inc.
15.3.4. Translumina GmbH
15.3.5. Relisys Medical Devices Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHAI
FIGURE 24. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 26. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MEDIUM STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MEDIUM STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THICK STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THICK STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THIN STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THIN STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MEDIUM STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MEDIUM STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THICK STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THICK STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THIN STRUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY THIN STRUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY NSTEMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY NSTEMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STEMI, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STEMI, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BIFURCATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BIFURCATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LARGE VESSEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LARGE VESSEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MULTI VESSEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MULTI VESSEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SINGLE VESSEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SINGLE VESSEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SMALL VESSEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SMALL VESSEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CARDIOLOGY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CARDIOLOGY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIRECT TENDERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIRECT TENDERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY WHOLESALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ONLINE CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY WHOLESALE DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY WHOLESALE DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 154. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 155. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 156. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 157. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 160. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 161. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 162. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 163. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 166. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 167. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 168. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 169. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY BALLOON EXPANDABLE, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY MYOCARDIAL INFARCTION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY OFFLINE CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioabsorbable Sirolimus-eluting Coronary Stent System market report include:
  • BIOTRONIK SE & Co. KG
  • Elixir Medical Corporation
  • REVA Medical, Inc.
  • Translumina GmbH
  • Relisys Medical Devices Limited

Related Topics

Related Reports

Bioabsorbable Eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expandable), Drug Type (Biolimus, Everolimus, Sirolimus), Polymer Type, Indication, End User - Global Forecast 2025-2030 - Product Image

Bioabsorbable Eluting Coronary Stent System Market by Product Type (Balloon Expandable, Self Expandable), Drug Type (Biolimus, Everolimus, Sirolimus), Polymer Type, Indication, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Cobalt Chromium Coronary Stent Market by Stent Type, Coating Type, Generation, End User, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Cobalt Chromium Coronary Stent Market by Stent Type, Coating Type, Generation, End User, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Coronary Stent Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033 - Product Image

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.